Hyo-Min Park

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Recombinant Human

Inflammatory Response

Top Venues

Pharmaceuticals (Basel, Switzerland)

BioFactors (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Hyo-Min Park, Jae-Young Park, Na-Yeon Kim, Hyemoon Kim, Hong-Gyum Kim, Dong-Ju Son, Jin Tae Hong, Do-Young Yoon
Recombinant Human IL-32θ Induces Polarization Into M1-like Macrophage in Human Monocytic Cells. Immune network 24 (3) (2024)
Hyo-Min Park, Jae-Young Park, Na-Yeon Kim, Hyemoon Kim, Hong-Gyum Kim, Dong-Ju Son, Jin Tae Hong, Do-Young Yoon
Recombinant Human IL-32θ Induces Polarization Into M1-like Macrophage in Human Monocytic Cells. Immune network 24 (3) (2024)
Hyo-Min Park, Jae-Young Park, Na-Yeon Kim, Jinju Kim, Thu-Huyen Pham, Jin Tae Hong, Do-Young Yoon
Modulatory effects of point-mutated IL-32θ (A94V) on tumor progression in triple-negative breast cancer cells. BioFactors (Oxford, England) (2023)
Seonhwa Kim, Na-Yeon Kim, Jae-Young Park, Hyo-Min Park, Chae-Min Lim, Jinju Kim, Hee Pom Lee, Jin Tae Hong, Do-Young Yoon
MMPP Exerts Anti-Inflammatory Effects by Suppressing MD2-Dependent NF-κB and JNK/AP-1 Pathways in THP-1 Monocytes. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Seonhwa Kim, Na-Yeon Kim, Jae-Young Park, Hyo-Min Park, Chae-Min Lim, Jinju Kim, Hee Pom Lee, Jin Tae Hong, Do-Young Yoon
MMPP Exerts Anti-Inflammatory Effects by Suppressing MD2-Dependent NF-κB and JNK/AP-1 Pathways in THP-1 Monocytes. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Seonhwa Kim, Na-Yeon Kim, Jae-Young Park, Hyo-Min Park, Chae-Min Lim, Jinju Kim, Hee Pom Lee, Jin Tae Hong, Do-Young Yoon
MMPP Exerts Anti-Inflammatory Effects by Suppressing MD2-Dependent NF-κB and JNK/AP-1 Pathways in THP-1 Monocytes. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Thu-Huyen Pham, Hyo-Min Park, Jinju Kim, Jin Tae Hong, Do-Young Yoon
Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells. International journal of molecular sciences 22 (9) (2021)
Thu-Huyen Pham, Hyo-Min Park, Jinju Kim, Jin Tae Hong, Do-Young Yoon
STAT3 and p53: Dual Target for Cancer Therapy. Biomedicines 8 (12) (2020)